|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He S, Del Viso F, Chen CY, Ikmi A, Kroesen
AE and Gibson MC: An axial Hox code controls tissue segmentation
and body patterning in Nematostella vectensis. Science.
361:1377–1380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holland PW: Evolution of homeobox genes.
Wiley Interdiscip Rev Dev Biol. 2:31–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stoffers DA, Heller RS, Miller CP and
Habener JF: Developmental expression of the homeodomain protein
IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional
reporter. Endocrinology. 140:5374–5381. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma J, Chen M, Wang J, Xia HH, Zhu S, Liang
Y, Gu Q, Qiao L, Dai Y, Zou B, et al: Pancreatic duodenal
homeobox-1 (PDX1) functions as a tumor suppressor in gastric
cancer. Carcinogenesis. 29:1327–1333. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guz Y, Montminy MR, Stein R, Leonard J,
Gamer LW, Wright CV and Teitelman G: Expression of murine STF-1, a
putative insulin gene transcription factor, in beta cells of
pancreas, duodenal epithelium and pancreatic exocrine and endocrine
progenitors during ontogeny. Development. 121:11–18.
1995.PubMed/NCBI
|
|
9
|
Liu T, Gou SM, Wang CY, Wu HS, Xiong JX
and Zhou F: Pancreas duodenal homeobox-1 expression and
significance in pancreatic cancer. World J Gastroenterol.
13:2615–2618. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herring BP, Kriegel AM and Hoggatt AM:
Identification of Barx2b, a serum response factor-associated
homeodomain protein. J Biol Chem. 276:14482–14489. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naka T and Yokose S: Immunohistochemical
localization of barx2 in the developing fetal mouse submandibular
glands. Acta Histochem Cytochem. 42:47–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meech R, Edelman DB, Jones FS and
Makarenkova HP: The homeobox transcription factor Barx2 regulates
chondrogenesis during limb development. Development. 132:2135–2146.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Olson LE, Zhang J, Taylor H, Rose DW and
Rosenfeld MG: Barx2 functions through distinct corepressor classes
to regulate hair follicle remodeling. Proc Natl Acad Sci USA.
102:3708–3713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jones FS, Kioussi C, Copertino DW,
Kallunki P, Holst BD and Edelman GM: Barx2, a new homeobox gene of
the Bar class, is expressed in neural and craniofacial structures
during development. Proc Natl Acad Sci USA. 94:2632–2637. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stevens TA, Iacovoni JS, Edelman DB and
Meech R: Identification of novel binding elements and gene targets
for the homeodomain protein BARX2. J Biol Chem. 279:14520–14530.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mi Y, Zhao S, Zhou C, Weng J, Li J, Wang
Z, Sun H, Tang H, Zhang X, Sun X, et al: Downregulation of homeobox
gene Barx2 increases gastric cancer proliferation and metastasis
and predicts poor patient outcomes. Oncotarget. 7:60593–60608.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sellar GC, Li L, Watt KP, Nelkin BD,
Rabiasz GJ, Stronach EA, Miller EP, Porteous DJ, Smyth JF and Gabra
H: BARX2 induces cadherin 6 expression and is a functional
suppressor of ovarian cancer progression. Cancer Res. 61:6977–6981.
2001.PubMed/NCBI
|
|
18
|
Stevens TA and Meech R: BARX2 and estrogen
receptor-alpha (ESR1) coordinately regulate the production of
alternatively spliced ESR1 isoforms and control breast cancer cell
growth and invasion. Oncogene. 25:5426–5435. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Zhang JX, Huang LL, He LJ, Liao
YJ, Lai YR, Deng HX, Tian XP, Kung HF, Xie D and Zhu SL: Low
expression of BARX2 in human primary hepatocellular carcinoma
correlates with metastasis and predicts poor prognosis. Hepatol
Res. 45:228–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mi Y, Zhao S, Zhang W, Zhang D, Weng J,
Huang K, Sun H, Tang H, Zhang X, Sun X, et al: Down-regulation of
Barx2 predicts poor survival in colorectal cancer. Biochem Biophys
Res Commun. 478:67–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen H, Zhang M, Zhang W, Li Y, Zhu J,
Zhang X, Zhao L, Zhu S and Chen B: Downregulation of BarH-like
homeobox 2 promotes cell proliferation, migration and aerobic
glycolysis through Wnt/β-catenin signaling, and predicts a poor
prognosis in non-small cell lung carcinoma. Thorac Cancer.
9:390–399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong NA, Britton MP, Choi GS, Stanton TK,
Bicknell DC, Wilding JL and Bodmer WF: Loss of CDX1 expression in
colorectal carcinoma: Promoter methylation, mutation, and loss of
heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci USA.
101:574–579. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo M, House MG, Suzuki H, Ye Y, Brock MV,
Lu F, Liu Z, Rustgi AK and Herman JG: Epigenetic silencing of CDX2
is a feature of squamous esophageal cancer. Int J Cancer.
121:1219–1226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma J, Wang JD, Zhang WJ, Zou B, Chen WJ,
Lam CS, Chen MH, Pang R, Tan VP, Hung IF, et al: Promoter
hypermethylation and histone hypoacetylation contribute to
pancreatic-duodenal homeobox 1 silencing in gastric cancer.
Carcinogenesis. 31:1552–1560. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ushijima T: Detection and interpretation
of altered methylation patterns in cancer cells. Nat Rev Cancer.
5:223–231. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao F, Xuan Z, Liu L and Zhang MQ: TRED:
A transcriptional regulatory element database and a platform for in
silico gene regulation studies. Nucleic Acids Res. 33
(Suppl):D103–D107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li LC and Dahiya R: MethPrimer: Designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sander GR and Powell BC: Expression of the
homeobox gene barx2 in the gut. J Histochem Cytochem. 52:541–544.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Verbrugge I, Johnstone RW and Smyth MJ:
SnapShot: Extrinsic apoptosis pathways. Cell. 143:1192–1192.e2,
1192.e1-1192.e2. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Green DR and Llambi F: Cell death
signaling. Cold Spring Harb Perspect Biol. 7:72015. View Article : Google Scholar
|
|
33
|
Chiurillo MA: Role of the Wnt/β-catenin
pathway in gastric cancer: An in-depth literature review. World J
Exp Med. 5:84–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhuang L, Hulin JA, Gromova A, Tran Nguyen
TD, Yu RT, Liddle C, Downes M, Evans RM, Makarenkova HP and Meech
R: Barx2 and Pax7 have antagonistic functions in regulation of wnt
signaling and satellite cell differentiation. Stem Cells.
32:1661–1673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang G, Liu J, Cai Y, Chen J, Xie W, Kong
X, Huang W, Guo H, Zhao X, Lu Y, et al: Loss of Barx1 promotes
hepatocellular carcinoma metastasis through up-regulating MGAT5 and
MMP9 expression and indicates poor prognosis. Oncotarget.
8:71867–71880. 2017.PubMed/NCBI
|
|
36
|
Chen C, Lu Y, Liu J, Li L, Zhao N and Lin
B: Genome-wide ChIP-seq analysis of TCF4 binding regions in
colorectal cancer cells. Int J Clin Exp Med. 7:4253–4259.
2014.PubMed/NCBI
|
|
37
|
Debebe A, Medina V, Chen CY, Mahajan IM,
Jia C, Fu D, He L, Zeng N, Stiles BW, Chen CL, et al: Wnt/β-catenin
activation and macrophage induction during liver cancer development
following steatosis. Oncogene. 36:6020–6029. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sarkar A, Huebner AJ, Sulahian R, Anselmo
A, Xu X, Flattery K, Desai N, Sebastian C, Yram MA, Arnold K, et
al: Sox2 suppresses gastric tumorigenesis in mice. Cell Rep.
16:1929–1941. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Laurent A, Calabrese M, Warnatz HJ, Yaspo
ML, Tkachuk V, Torres M, Blasi F and Penkov D: ChIP-Seq and RNA-Seq
analyses identify components of the Wnt and Fgf signaling pathways
as Prep1 target genes in mouse embryonic stem cells. PLoS One.
10:e01225182015. View Article : Google Scholar : PubMed/NCBI
|
